4 Einträge gefunden

1. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

   1. Lioznov, Michael
   2. El-Cheikh, J
   3. Hoffmann, Friedericke
   4. Hildebrandt, York
   5. Ayuketang Ayuk, Francis
   6. Wolschke, Christine
   7. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE
2. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

   1. Kröger, Nicolaus
   2. Alchalby, Haefaa
   3. Klyuchnikov, Evgeny
   4. Badbaran, Anita
   5. Hildebrandt, York
   6. Ayuketang Ayuk, Francis
   7. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
3. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.

   1. Bacher, Ulrike
   2. Asenova, Svetlana
   3. Badbaran, Anita
   4. Zander, Axel R.
   5. Alchalby, Haefaa
   6. Fehse, Boris
   7. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
4. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.

   1. Kröger, Nicolaus
   2. Zagrivnaja, Maria
   3. Schwartz, Sabine
   4. Badbaran, Anita
   5. Zabelina, Tatjana
   6. Lioznov, Michael
   7. Ayuketang Ayuk, Francis

   2006 - Forschungsinformationssystem des UKE